Hydroxyzine Hydrochloride Tablet, Film Coated
FDA Label NDC 55154-2148

13 label sections · Submitted to the FDA by Cardinal Health 107, Llc · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Cardinal Health 107, Llc for the product Hydroxyzine Hydrochloride (NDC 55154-2148). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding description, clinical pharmacology, indications and usage, contraindications, nursing mothers, precautions, geriatric use, acute generalized exanthematous pustulosis (agep), and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package/Label Display Panel

NDC 55154-2148-0

HydrOXYzine Hydrochloride

Tablets, USP 25 mg

10 TABLETS

25mg Bag Label (Image 01)

25mg Bag Label (Image 01)

* Please review the disclaimer below.